Marcelo M Kerstenetzky

Long-term effect of imiglucerase in Latin American children with Gaucher disease type 1: lessons from the International Collaborative Gaucher Group

A. Linares, I. Sarmiento, A. Gwosdow, 2014 .

Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

J. Charrow, J. Goldblatt, C. Hollak, 2012, Journal of Inherited Metabolic Disease.

Long-term impact of early initiation of enzyme replacement therapy in 34 MPS VI patients: A resurvey study.

C. Kim, C. Lourenço, E. Ribeiro, 2021, Molecular genetics and metabolism.

Long-term clinical outcomes in type 1 Gaucher disease following 10 years of imiglucerase treatment

J. Charrow, J. Goldblatt, C. Hollak, 2013, Journal of Inherited Metabolic Disease.

[Gaucher disease in Latin America. A report from the Gaucher Disease International Registry and the Latin American Group for Gaucher Disease].

A. Linares, J. Cabello, G. Drelichman, 2012, Medicina.

Long-term effect of imiglucerase in Latin American children with Gaucher disease type 1: lessons from the International Collaborative Gaucher Group Gaucher Registry

A. Linares, I. Sarmiento, A. Gwosdow, 2014, BMC Hematology.